PARP1 and cancer: In NAPRT positive tumors, cancer cells have an adequate supply of NAD+, allowing PARP activation which is required for oxidative and DNA damage protection.216,230 Thereby, NAPRT overexpression can contribute to resistance to NAMPT inhibitors and DNA-damaging drugs treatment.